Prior Authorization Recommended

Prior authorization is recommended when light- or laser-based therapy is requested for indications where standard therapies have not been effective, are not tolerated, or are contraindicated. Requests should include documentation of prior standard therapy trials (or clear rationale why such therapies are inappropriate) before device-based therapy is authorized.

• Prior authorization recommended for acne: document trials of guideline-recommended topical and/or oral therapies and reason for failure/intolerance before approving photodynamic or other light/laser therapies.
• Prior authorization recommended for onychomycosis: document trials of topical and/or systemic antifungals and rationale for inadequate response before approving device therapy.
• Prior authorization recommended for rosacea/device-based therapy: document trial of appropriate topical/systemic medical therapy unless contraindicated; consider authorization for persistent central facial erythema, telangiectasia, or phyma when documentation supports medical necessity.
• For infantile hemangiomas: include consultation notes from a hemangioma specialist and rationale for laser therapy timing (e.g., residual skin changes after involution or specific indications for earlier treatment).

Documentation Sufficiency

Medical record documentation must fully support the medical necessity for the requested services. Lack of adequate documentation may result in denial or non-coverage. Benefit coverage is determined by applicable federal, state, and contractual requirements and applicable laws; provision of records for review does not guarantee coverage or payment.

• Patient medical record must include relevant medical history, focused physical examination findings, and results of pertinent diagnostic tests or procedures.
• Documentation must be legible, retained in the patient record, and made available upon request.
• Incomplete documentation that does not substantiate the medical necessity criteria described in the policy may lead to denial or non-coverage.

Suggested Documentation to Support Medical Necessity

When submitting requests for device-based light or laser therapies, include the following suggested supporting documentation to demonstrate medical necessity. The presence of these items supports medical review but does not guarantee coverage.

• Clinical indication and description of targeted lesions (location, size, distribution) and baseline severity (e.g., IGA for acne, Onychomycosis Severity Index for OM, erythema/telangiectasia severity for rosacea).
• Detailed treatment history documenting prior standard therapies (topical, oral, systemic, duration, dosing), response to each therapy, and reasons for discontinuation or intolerance.
• Relevant diagnostic test results (e.g., KOH or fungal culture for suspected onychomycosis) when applicable to the indication.
• Specialist consultation notes when recommended by guidelines (e.g., hemangioma specialist for infantile hemangiomas).
• Proposed treatment plan including device type, settings (if available), number of planned sessions, treatment intervals, and anticipated therapeutic goals.
• Documentation of patient counseling on alternative therapies, risks, benefits, and expected outcomes.
• For continuation or repeat therapy: documentation of clinical response to prior device treatments with objective measures or photographic evidence when available.

Evidence and Coverage Risk

Decisions may be impacted by the overall strength and quality of evidence for the requested indication. Treatments supported only by limited, heterogeneous, or low-quality evidence may be subject to denial unless compelling, individualized documentation is provided.

• Acne vulgaris and onychomycosis: submit strong supporting documentation of prior treatments and clinical rationale, as evidence is mixed or insufficient for many device therapies.
• Rosacea and rhinophyma: provide severity documentation and evidence of failed or inadequate response to medical therapy when requesting device-based treatments.
• Coding and state applicability: include appropriate procedure and diagnosis codes; note that some codes (e.g., CPT 17999) may not be covered by certain state Medicaid programs (North Carolina).